CG Oncology target price raised to $91 from $84 by Wedbush
CGON•Wedbush raised its target price for CG Oncology to $91 from $84.
Related News

ADMA Biologics CEO Adam S. Grossman reports sale of $288,120 in common shares
ADMA•

IBM study finds only 18% of chief AI officers fully control AI investment decisions
IBM•

Shell starts gas production at Rosmari-Marjoram project in Malaysia
SHEL•

FDA approves Novartis' Cosentyx for polymyalgia rheumatica
NVS•

Gold hovers near more than one-year low as firm dollar, Fed-hike bets weigh
GLD•